- Richard Feachem, director and professor of global health1,
- Gavin Yamey, co-lead—evidence to policy initiative1,
- Christina Schrade, co-lead—evidence to policy initiative2
- 1Global Health Group, University of California San Francisco, 50 Beale Street, Suite 1200, San Francisco, CA 94105, USA
- 2SEEK Development, C Schrade Strategic and Organizational Consultants, Greifswalder Straße 34-25, 10405 Berlin, Germany
- feachemr{at}globalhealth.ucsf.edu
The past decade has been a “golden window” for global health.1 New disease specific health initiatives and major new funding programmes have contributed to impressive gains.2 3 In 2008, for example, 10 000 fewer children were dying each day than in 1990.3 But there are disturbing signs that the window may be closing.
Donor agencies have warned African countries that financial help for HIV treatment programmes cannot be assured.1 The Global Fund to Fight AIDS, tuberculosis, and malaria and the Global Alliance for Vaccines and Immunisation (GAVI Alliance) face serious funding shortfalls. The Spanish government just announced that it will cut foreign aid by €600m (£506m; $734m) as part of its austerity measures, and other donor governments seem likely to follow suit.4 Without sustained funding to strengthen the fragile health infrastructure of developing countries, the millennium development goals are unlikely to be reached.
How will the global health community respond? One risk is that the various sub-communities, or silos, such as those working on HIV, malaria, vaccines, or health systems, will advocate and compete for their own stake in the shrinking pot of donor money.
A more rational response would be for the community to come together and agree on a “cross cutting” agenda for global health. Such an agenda should focus on how to get the overall global health architecture right, and how to ensure maximum return for every dollar invested.
This agenda should tackle four key areas. A better …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012